nodes	percent_of_prediction	percent_of_DWPC	metapath
Gentamicin—LRP2—prostate gland—urinary bladder cancer	0.0665	0.338	CbGeAlD
Gentamicin—LRP2—epithelium—urinary bladder cancer	0.0488	0.248	CbGeAlD
Gentamicin—LRP2—renal system—urinary bladder cancer	0.0453	0.23	CbGeAlD
Gentamicin—LRP2—female reproductive system—urinary bladder cancer	0.0363	0.184	CbGeAlD
Gentamicin—LRP2—Vitamin B12 Metabolism—MPO—urinary bladder cancer	0.00816	0.127	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—SOD2—urinary bladder cancer	0.00513	0.0796	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—MTHFR—urinary bladder cancer	0.00451	0.0701	CbGpPWpGaD
Gentamicin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.00237	0.0368	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00226	0.035	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Gemcitabine—urinary bladder cancer	0.00209	0.00283	CcSEcCtD
Gentamicin—Stomatitis—Gemcitabine—urinary bladder cancer	0.00208	0.00281	CcSEcCtD
Gentamicin—Injection site pain—Doxorubicin—urinary bladder cancer	0.00207	0.0028	CcSEcCtD
Gentamicin—Neuropathy peripheral—Fluorouracil—urinary bladder cancer	0.00206	0.00278	CcSEcCtD
Gentamicin—Vomiting—Mitomycin—urinary bladder cancer	0.00204	0.00277	CcSEcCtD
Gentamicin—Stomatitis—Fluorouracil—urinary bladder cancer	0.00204	0.00277	CcSEcCtD
Gentamicin—Rash—Mitomycin—urinary bladder cancer	0.00203	0.00274	CcSEcCtD
Gentamicin—Dermatitis—Mitomycin—urinary bladder cancer	0.00203	0.00274	CcSEcCtD
Gentamicin—Headache—Mitomycin—urinary bladder cancer	0.00201	0.00273	CcSEcCtD
Gentamicin—Alopecia—Thiotepa—urinary bladder cancer	0.00201	0.00272	CcSEcCtD
Gentamicin—Hypocalcaemia—Epirubicin—urinary bladder cancer	0.00199	0.0027	CcSEcCtD
Gentamicin—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.00199	0.00269	CcSEcCtD
Gentamicin—Erythema—Thiotepa—urinary bladder cancer	0.00198	0.00268	CcSEcCtD
Gentamicin—Oliguria—Epirubicin—urinary bladder cancer	0.00198	0.00268	CcSEcCtD
Gentamicin—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.00196	0.00265	CcSEcCtD
Gentamicin—Neuropathy peripheral—Cisplatin—urinary bladder cancer	0.00195	0.00264	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—TNF—urinary bladder cancer	0.00194	0.0302	CbGpPWpGaD
Gentamicin—Stomatitis—Cisplatin—urinary bladder cancer	0.00194	0.00262	CcSEcCtD
Gentamicin—Extravasation—Doxorubicin—urinary bladder cancer	0.00194	0.00262	CcSEcCtD
Gentamicin—Nausea—Mitomycin—urinary bladder cancer	0.00191	0.00259	CcSEcCtD
Gentamicin—Hypoaesthesia—Fluorouracil—urinary bladder cancer	0.00187	0.00254	CcSEcCtD
Gentamicin—Hypocalcaemia—Doxorubicin—urinary bladder cancer	0.00184	0.0025	CcSEcCtD
Gentamicin—Oliguria—Doxorubicin—urinary bladder cancer	0.00183	0.00248	CcSEcCtD
Gentamicin—Anaemia—Thiotepa—urinary bladder cancer	0.00183	0.00248	CcSEcCtD
Gentamicin—Neuropathy peripheral—Etoposide—urinary bladder cancer	0.00179	0.00242	CcSEcCtD
Gentamicin—Stomatitis—Etoposide—urinary bladder cancer	0.00178	0.0024	CcSEcCtD
Gentamicin—Leukopenia—Thiotepa—urinary bladder cancer	0.00177	0.0024	CcSEcCtD
Gentamicin—Salivary hypersecretion—Epirubicin—urinary bladder cancer	0.00177	0.0024	CcSEcCtD
Gentamicin—Visual impairment—Cisplatin—urinary bladder cancer	0.00172	0.00233	CcSEcCtD
Gentamicin—Convulsion—Thiotepa—urinary bladder cancer	0.00172	0.00232	CcSEcCtD
Gentamicin—Hypertension—Thiotepa—urinary bladder cancer	0.00171	0.00232	CcSEcCtD
Gentamicin—Agranulocytosis—Etoposide—urinary bladder cancer	0.0017	0.0023	CcSEcCtD
Gentamicin—Alopecia—Gemcitabine—urinary bladder cancer	0.00169	0.00229	CcSEcCtD
Gentamicin—Arthralgia—Thiotepa—urinary bladder cancer	0.00169	0.00228	CcSEcCtD
Gentamicin—Erythema—Gemcitabine—urinary bladder cancer	0.00167	0.00226	CcSEcCtD
Gentamicin—Tinnitus—Cisplatin—urinary bladder cancer	0.00166	0.00225	CcSEcCtD
Gentamicin—Alopecia—Fluorouracil—urinary bladder cancer	0.00166	0.00225	CcSEcCtD
Gentamicin—Salivary hypersecretion—Doxorubicin—urinary bladder cancer	0.00164	0.00222	CcSEcCtD
Gentamicin—Erythema—Fluorouracil—urinary bladder cancer	0.00164	0.00222	CcSEcCtD
Gentamicin—Confusional state—Thiotepa—urinary bladder cancer	0.00163	0.00221	CcSEcCtD
Gentamicin—Hypoaesthesia—Etoposide—urinary bladder cancer	0.00163	0.0022	CcSEcCtD
Gentamicin—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00158	0.00214	CcSEcCtD
Gentamicin—Alopecia—Cisplatin—urinary bladder cancer	0.00158	0.00214	CcSEcCtD
Gentamicin—Erythema—Cisplatin—urinary bladder cancer	0.00155	0.0021	CcSEcCtD
Gentamicin—Anaemia—Gemcitabine—urinary bladder cancer	0.00154	0.00209	CcSEcCtD
Gentamicin—Phlebitis—Epirubicin—urinary bladder cancer	0.00154	0.00208	CcSEcCtD
Gentamicin—Anaemia—Fluorouracil—urinary bladder cancer	0.00151	0.00205	CcSEcCtD
Gentamicin—Visual disturbance—Methotrexate—urinary bladder cancer	0.00149	0.00202	CcSEcCtD
Gentamicin—Leukopenia—Gemcitabine—urinary bladder cancer	0.00149	0.00202	CcSEcCtD
Gentamicin—Vascular purpura—Epirubicin—urinary bladder cancer	0.00148	0.002	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.00147	0.00199	CcSEcCtD
Gentamicin—Leukopenia—Fluorouracil—urinary bladder cancer	0.00147	0.00199	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Methotrexate—urinary bladder cancer	0.00146	0.00198	CcSEcCtD
Gentamicin—LRP2—Disease—GSTO2—urinary bladder cancer	0.00146	0.0226	CbGpPWpGaD
Gentamicin—Paraesthesia—Thiotepa—urinary bladder cancer	0.00145	0.00197	CcSEcCtD
Gentamicin—Alopecia—Etoposide—urinary bladder cancer	0.00144	0.00196	CcSEcCtD
Gentamicin—Lethargy—Methotrexate—urinary bladder cancer	0.00144	0.00196	CcSEcCtD
Gentamicin—Hypertension—Gemcitabine—urinary bladder cancer	0.00144	0.00195	CcSEcCtD
Gentamicin—Anaemia—Cisplatin—urinary bladder cancer	0.00144	0.00194	CcSEcCtD
Gentamicin—Phlebitis—Doxorubicin—urinary bladder cancer	0.00142	0.00193	CcSEcCtD
Gentamicin—Convulsion—Fluorouracil—urinary bladder cancer	0.00142	0.00192	CcSEcCtD
Gentamicin—Arthralgia—Gemcitabine—urinary bladder cancer	0.00142	0.00192	CcSEcCtD
Gentamicin—Decreased appetite—Thiotepa—urinary bladder cancer	0.00141	0.0019	CcSEcCtD
Gentamicin—Leukopenia—Cisplatin—urinary bladder cancer	0.00139	0.00188	CcSEcCtD
Gentamicin—Purpura—Epirubicin—urinary bladder cancer	0.00137	0.00186	CcSEcCtD
Gentamicin—Vascular purpura—Doxorubicin—urinary bladder cancer	0.00137	0.00186	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.00137	0.00185	CcSEcCtD
Gentamicin—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00136	0.00184	CcSEcCtD
Gentamicin—Lethargy—Epirubicin—urinary bladder cancer	0.00135	0.00183	CcSEcCtD
Gentamicin—Confusional state—Fluorouracil—urinary bladder cancer	0.00135	0.00183	CcSEcCtD
Gentamicin—Convulsion—Cisplatin—urinary bladder cancer	0.00135	0.00182	CcSEcCtD
Gentamicin—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00134	0.00181	CcSEcCtD
Gentamicin—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00133	0.0018	CcSEcCtD
Gentamicin—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00133	0.0018	CcSEcCtD
Gentamicin—Anaemia—Etoposide—urinary bladder cancer	0.00132	0.00178	CcSEcCtD
Gentamicin—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00131	0.00177	CcSEcCtD
Gentamicin—LRP2—Metabolism—GSTZ1—urinary bladder cancer	0.00129	0.02	CbGpPWpGaD
Gentamicin—Urticaria—Thiotepa—urinary bladder cancer	0.00128	0.00174	CcSEcCtD
Gentamicin—Vertigo—Etoposide—urinary bladder cancer	0.00128	0.00173	CcSEcCtD
Gentamicin—Body temperature increased—Thiotepa—urinary bladder cancer	0.00128	0.00173	CcSEcCtD
Gentamicin—Leukopenia—Etoposide—urinary bladder cancer	0.00127	0.00172	CcSEcCtD
Gentamicin—Purpura—Doxorubicin—urinary bladder cancer	0.00127	0.00172	CcSEcCtD
Gentamicin—Hypotension—Gemcitabine—urinary bladder cancer	0.00127	0.00172	CcSEcCtD
Gentamicin—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00127	0.00172	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.00127	0.00171	CcSEcCtD
Gentamicin—Lethargy—Doxorubicin—urinary bladder cancer	0.00125	0.00169	CcSEcCtD
Gentamicin—Hypotension—Fluorouracil—urinary bladder cancer	0.00125	0.00169	CcSEcCtD
Gentamicin—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00124	0.00168	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00124	0.00168	CcSEcCtD
Gentamicin—Convulsion—Etoposide—urinary bladder cancer	0.00123	0.00167	CcSEcCtD
Gentamicin—Hypertension—Etoposide—urinary bladder cancer	0.00123	0.00166	CcSEcCtD
Gentamicin—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00122	0.00165	CcSEcCtD
Gentamicin—LRP2—Metabolism—GSTO2—urinary bladder cancer	0.00122	0.0189	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—NAT1—urinary bladder cancer	0.00122	0.0189	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00122	0.00165	CcSEcCtD
Gentamicin—Eosinophilia—Methotrexate—urinary bladder cancer	0.00121	0.00164	CcSEcCtD
Gentamicin—Hypokalaemia—Epirubicin—urinary bladder cancer	0.00121	0.00163	CcSEcCtD
Gentamicin—Paraesthesia—Fluorouracil—urinary bladder cancer	0.0012	0.00163	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.0012	0.0186	CbGpPWpGaD
Gentamicin—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00119	0.00161	CcSEcCtD
Gentamicin—Hypotension—Cisplatin—urinary bladder cancer	0.00118	0.0016	CcSEcCtD
Gentamicin—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00118	0.0016	CcSEcCtD
Gentamicin—Confusional state—Etoposide—urinary bladder cancer	0.00117	0.00159	CcSEcCtD
Gentamicin—Muscular weakness—Epirubicin—urinary bladder cancer	0.00117	0.00158	CcSEcCtD
Gentamicin—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00116	0.00157	CcSEcCtD
Gentamicin—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00116	0.00157	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00116	0.00156	CcSEcCtD
Gentamicin—Pruritus—Thiotepa—urinary bladder cancer	0.00114	0.00155	CcSEcCtD
Gentamicin—Paraesthesia—Cisplatin—urinary bladder cancer	0.00114	0.00154	CcSEcCtD
Gentamicin—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00114	0.00154	CcSEcCtD
Gentamicin—Eosinophilia—Epirubicin—urinary bladder cancer	0.00113	0.00153	CcSEcCtD
Gentamicin—LRP2—Disease—SLC19A1—urinary bladder cancer	0.00113	0.0176	CbGpPWpGaD
Gentamicin—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00112	0.00152	CcSEcCtD
Gentamicin—LRP2—Metabolism—UGT2B7—urinary bladder cancer	0.00112	0.0173	CbGpPWpGaD
Gentamicin—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.00112	0.00151	CcSEcCtD
Gentamicin—LRP2—Disease—PRSS3—urinary bladder cancer	0.0011	0.0171	CbGpPWpGaD
Gentamicin—Decreased appetite—Cisplatin—urinary bladder cancer	0.0011	0.00149	CcSEcCtD
Gentamicin—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.0011	0.00149	CcSEcCtD
Gentamicin—Hypotension—Etoposide—urinary bladder cancer	0.00109	0.00147	CcSEcCtD
Gentamicin—Muscular weakness—Doxorubicin—urinary bladder cancer	0.00108	0.00146	CcSEcCtD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.00108	0.0167	CbGpPWpGaD
Gentamicin—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00108	0.00146	CcSEcCtD
Gentamicin—Dizziness—Thiotepa—urinary bladder cancer	0.00107	0.00145	CcSEcCtD
Gentamicin—Stomatitis—Methotrexate—urinary bladder cancer	0.00106	0.00144	CcSEcCtD
Gentamicin—Urticaria—Fluorouracil—urinary bladder cancer	0.00106	0.00144	CcSEcCtD
Gentamicin—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00106	0.00143	CcSEcCtD
Gentamicin—LRP2—Disease—HDAC4—urinary bladder cancer	0.00105	0.0164	CbGpPWpGaD
Gentamicin—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00105	0.00142	CcSEcCtD
Gentamicin—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00104	0.00141	CcSEcCtD
Gentamicin—Paraesthesia—Etoposide—urinary bladder cancer	0.00104	0.00141	CcSEcCtD
Gentamicin—Weight decreased—Epirubicin—urinary bladder cancer	0.00104	0.0014	CcSEcCtD
Gentamicin—Vomiting—Thiotepa—urinary bladder cancer	0.00103	0.00139	CcSEcCtD
Gentamicin—Rash—Thiotepa—urinary bladder cancer	0.00102	0.00138	CcSEcCtD
Gentamicin—Dermatitis—Thiotepa—urinary bladder cancer	0.00102	0.00138	CcSEcCtD
Gentamicin—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00102	0.00138	CcSEcCtD
Gentamicin—Headache—Thiotepa—urinary bladder cancer	0.00101	0.00137	CcSEcCtD
Gentamicin—Decreased appetite—Etoposide—urinary bladder cancer	0.00101	0.00137	CcSEcCtD
Gentamicin—LRP2—Metabolism—CYP4B1—urinary bladder cancer	0.001	0.0156	CbGpPWpGaD
Gentamicin—Body temperature increased—Cisplatin—urinary bladder cancer	0.001	0.00136	CcSEcCtD
Gentamicin—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.001	0.00135	CcSEcCtD
Gentamicin—Stomatitis—Epirubicin—urinary bladder cancer	0.000995	0.00135	CcSEcCtD
Gentamicin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000986	0.00133	CcSEcCtD
Gentamicin—Pruritus—Gemcitabine—urinary bladder cancer	0.000963	0.0013	CcSEcCtD
Gentamicin—Nausea—Thiotepa—urinary bladder cancer	0.000961	0.0013	CcSEcCtD
Gentamicin—Weight decreased—Doxorubicin—urinary bladder cancer	0.000959	0.0013	CcSEcCtD
Gentamicin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000957	0.0013	CcSEcCtD
Gentamicin—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000953	0.00129	CcSEcCtD
Gentamicin—LRP2—Metabolism—SLC19A1—urinary bladder cancer	0.000949	0.0147	CbGpPWpGaD
Gentamicin—Pruritus—Fluorouracil—urinary bladder cancer	0.000946	0.00128	CcSEcCtD
Gentamicin—Visual impairment—Methotrexate—urinary bladder cancer	0.000944	0.00128	CcSEcCtD
Gentamicin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000934	0.00126	CcSEcCtD
Gentamicin—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000926	0.00125	CcSEcCtD
Gentamicin—LRP2—Metabolism—PRSS3—urinary bladder cancer	0.000925	0.0144	CbGpPWpGaD
Gentamicin—Urticaria—Etoposide—urinary bladder cancer	0.000923	0.00125	CcSEcCtD
Gentamicin—Stomatitis—Doxorubicin—urinary bladder cancer	0.000921	0.00125	CcSEcCtD
Gentamicin—Body temperature increased—Etoposide—urinary bladder cancer	0.000918	0.00124	CcSEcCtD
Gentamicin—Tinnitus—Methotrexate—urinary bladder cancer	0.000913	0.00124	CcSEcCtD
Gentamicin—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000912	0.00123	CcSEcCtD
Gentamicin—Dizziness—Fluorouracil—urinary bladder cancer	0.000885	0.0012	CcSEcCtD
Gentamicin—Visual impairment—Epirubicin—urinary bladder cancer	0.000883	0.0012	CcSEcCtD
Gentamicin—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000882	0.00119	CcSEcCtD
Gentamicin—Alopecia—Methotrexate—urinary bladder cancer	0.000865	0.00117	CcSEcCtD
Gentamicin—Vomiting—Gemcitabine—urinary bladder cancer	0.000865	0.00117	CcSEcCtD
Gentamicin—Rash—Gemcitabine—urinary bladder cancer	0.000858	0.00116	CcSEcCtD
Gentamicin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000857	0.00116	CcSEcCtD
Gentamicin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000856	0.00116	CcSEcCtD
Gentamicin—Tinnitus—Epirubicin—urinary bladder cancer	0.000855	0.00116	CcSEcCtD
Gentamicin—Erythema—Methotrexate—urinary bladder cancer	0.000853	0.00115	CcSEcCtD
Gentamicin—Headache—Gemcitabine—urinary bladder cancer	0.000852	0.00115	CcSEcCtD
Gentamicin—Vomiting—Fluorouracil—urinary bladder cancer	0.00085	0.00115	CcSEcCtD
Gentamicin—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000844	0.00114	CcSEcCtD
Gentamicin—Rash—Fluorouracil—urinary bladder cancer	0.000843	0.00114	CcSEcCtD
Gentamicin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000843	0.00114	CcSEcCtD
Gentamicin—Headache—Fluorouracil—urinary bladder cancer	0.000838	0.00113	CcSEcCtD
Gentamicin—LRP2—Disease—LIG1—urinary bladder cancer	0.000837	0.013	CbGpPWpGaD
Gentamicin—Pruritus—Etoposide—urinary bladder cancer	0.000822	0.00111	CcSEcCtD
Gentamicin—Visual impairment—Doxorubicin—urinary bladder cancer	0.000817	0.00111	CcSEcCtD
Gentamicin—Alopecia—Epirubicin—urinary bladder cancer	0.00081	0.0011	CcSEcCtD
Gentamicin—Nausea—Gemcitabine—urinary bladder cancer	0.000808	0.00109	CcSEcCtD
Gentamicin—Vomiting—Cisplatin—urinary bladder cancer	0.000806	0.00109	CcSEcCtD
Gentamicin—Rash—Cisplatin—urinary bladder cancer	0.0008	0.00108	CcSEcCtD
Gentamicin—Dermatitis—Cisplatin—urinary bladder cancer	0.000799	0.00108	CcSEcCtD
Gentamicin—Erythema—Epirubicin—urinary bladder cancer	0.000798	0.00108	CcSEcCtD
Gentamicin—Nausea—Fluorouracil—urinary bladder cancer	0.000795	0.00108	CcSEcCtD
Gentamicin—Tinnitus—Doxorubicin—urinary bladder cancer	0.000791	0.00107	CcSEcCtD
Gentamicin—Anaemia—Methotrexate—urinary bladder cancer	0.000788	0.00107	CcSEcCtD
Gentamicin—Dizziness—Etoposide—urinary bladder cancer	0.000768	0.00104	CcSEcCtD
Gentamicin—Vertigo—Methotrexate—urinary bladder cancer	0.000766	0.00104	CcSEcCtD
Gentamicin—Leukopenia—Methotrexate—urinary bladder cancer	0.000763	0.00103	CcSEcCtD
Gentamicin—Nausea—Cisplatin—urinary bladder cancer	0.000753	0.00102	CcSEcCtD
Gentamicin—Alopecia—Doxorubicin—urinary bladder cancer	0.000749	0.00101	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000741	0.0115	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—TYMP—urinary bladder cancer	0.000739	0.0115	CbGpPWpGaD
Gentamicin—Convulsion—Methotrexate—urinary bladder cancer	0.000739	0.001	CcSEcCtD
Gentamicin—Vomiting—Etoposide—urinary bladder cancer	0.000739	0.001	CcSEcCtD
Gentamicin—Erythema—Doxorubicin—urinary bladder cancer	0.000738	0.000999	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—HDAC4—urinary bladder cancer	0.000738	0.0115	CbGpPWpGaD
Gentamicin—Anaemia—Epirubicin—urinary bladder cancer	0.000737	0.000998	CcSEcCtD
Gentamicin—Rash—Etoposide—urinary bladder cancer	0.000732	0.000992	CcSEcCtD
Gentamicin—Dermatitis—Etoposide—urinary bladder cancer	0.000732	0.000991	CcSEcCtD
Gentamicin—Headache—Etoposide—urinary bladder cancer	0.000728	0.000985	CcSEcCtD
Gentamicin—Arthralgia—Methotrexate—urinary bladder cancer	0.000726	0.000983	CcSEcCtD
Gentamicin—Vertigo—Epirubicin—urinary bladder cancer	0.000717	0.00097	CcSEcCtD
Gentamicin—Leukopenia—Epirubicin—urinary bladder cancer	0.000714	0.000967	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.00071	0.011	CbGpPWpGaD
Gentamicin—Confusional state—Methotrexate—urinary bladder cancer	0.000702	0.00095	CcSEcCtD
Gentamicin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000696	0.000942	CcSEcCtD
Gentamicin—Convulsion—Epirubicin—urinary bladder cancer	0.000691	0.000936	CcSEcCtD
Gentamicin—Nausea—Etoposide—urinary bladder cancer	0.00069	0.000934	CcSEcCtD
Gentamicin—Hypertension—Epirubicin—urinary bladder cancer	0.000689	0.000933	CcSEcCtD
Gentamicin—Anaemia—Doxorubicin—urinary bladder cancer	0.000682	0.000924	CcSEcCtD
Gentamicin—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000681	0.000922	CcSEcCtD
Gentamicin—Arthralgia—Epirubicin—urinary bladder cancer	0.000679	0.00092	CcSEcCtD
Gentamicin—LRP2—Metabolism—NAT2—urinary bladder cancer	0.000669	0.0104	CbGpPWpGaD
Gentamicin—Vertigo—Doxorubicin—urinary bladder cancer	0.000663	0.000898	CcSEcCtD
Gentamicin—Leukopenia—Doxorubicin—urinary bladder cancer	0.000661	0.000895	CcSEcCtD
Gentamicin—Confusional state—Epirubicin—urinary bladder cancer	0.000657	0.000889	CcSEcCtD
Gentamicin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000651	0.000882	CcSEcCtD
Gentamicin—Hypotension—Methotrexate—urinary bladder cancer	0.00065	0.00088	CcSEcCtD
Gentamicin—Convulsion—Doxorubicin—urinary bladder cancer	0.00064	0.000866	CcSEcCtD
Gentamicin—LRP2—Disease—ENO2—urinary bladder cancer	0.000638	0.00991	CbGpPWpGaD
Gentamicin—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000638	0.000863	CcSEcCtD
Gentamicin—Hypertension—Doxorubicin—urinary bladder cancer	0.000637	0.000863	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000634	0.000858	CcSEcCtD
Gentamicin—Arthralgia—Doxorubicin—urinary bladder cancer	0.000629	0.000851	CcSEcCtD
Gentamicin—Paraesthesia—Methotrexate—urinary bladder cancer	0.000625	0.000846	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—GLI1—urinary bladder cancer	0.000618	0.0096	CbGpPWpGaD
Gentamicin—Hypotension—Epirubicin—urinary bladder cancer	0.000608	0.000824	CcSEcCtD
Gentamicin—Confusional state—Doxorubicin—urinary bladder cancer	0.000608	0.000822	CcSEcCtD
Gentamicin—LRP2—Disease—RBX1—urinary bladder cancer	0.000605	0.00939	CbGpPWpGaD
Gentamicin—Decreased appetite—Methotrexate—urinary bladder cancer	0.000605	0.000819	CcSEcCtD
Gentamicin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000603	0.000816	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000593	0.000803	CcSEcCtD
Gentamicin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.00059	0.000799	CcSEcCtD
Gentamicin—Paraesthesia—Epirubicin—urinary bladder cancer	0.000585	0.000792	CcSEcCtD
Gentamicin—LRP2—Metabolism—RRM2—urinary bladder cancer	0.000577	0.00896	CbGpPWpGaD
Gentamicin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000573	0.000776	CcSEcCtD
Gentamicin—Decreased appetite—Epirubicin—urinary bladder cancer	0.000566	0.000766	CcSEcCtD
Gentamicin—Hypotension—Doxorubicin—urinary bladder cancer	0.000563	0.000762	CcSEcCtD
Gentamicin—Urticaria—Methotrexate—urinary bladder cancer	0.000553	0.000748	CcSEcCtD
Gentamicin—Body temperature increased—Methotrexate—urinary bladder cancer	0.00055	0.000745	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000549	0.000743	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000547	0.00849	CbGpPWpGaD
Gentamicin—LRP2—Disease—JAG1—urinary bladder cancer	0.000541	0.00841	CbGpPWpGaD
Gentamicin—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000541	0.000732	CcSEcCtD
Gentamicin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000537	0.000726	CcSEcCtD
Gentamicin—LRP2—Metabolism—HPGDS—urinary bladder cancer	0.000534	0.0083	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ENO2—urinary bladder cancer	0.000534	0.0083	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000531	0.00825	CbGpPWpGaD
Gentamicin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000524	0.000709	CcSEcCtD
Gentamicin—LRP2—Metabolism—GSTT1—urinary bladder cancer	0.000518	0.00805	CbGpPWpGaD
Gentamicin—Urticaria—Epirubicin—urinary bladder cancer	0.000517	0.0007	CcSEcCtD
Gentamicin—Body temperature increased—Epirubicin—urinary bladder cancer	0.000515	0.000697	CcSEcCtD
Gentamicin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000513	0.000694	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.00051	0.00792	CbGpPWpGaD
Gentamicin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000497	0.000672	CcSEcCtD
Gentamicin—Pruritus—Methotrexate—urinary bladder cancer	0.000492	0.000666	CcSEcCtD
Gentamicin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00048	0.000649	CcSEcCtD
Gentamicin—Urticaria—Doxorubicin—urinary bladder cancer	0.000479	0.000648	CcSEcCtD
Gentamicin—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000476	0.000645	CcSEcCtD
Gentamicin—Pruritus—Epirubicin—urinary bladder cancer	0.000461	0.000624	CcSEcCtD
Gentamicin—Dizziness—Methotrexate—urinary bladder cancer	0.00046	0.000623	CcSEcCtD
Gentamicin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000444	0.000601	CcSEcCtD
Gentamicin—Vomiting—Methotrexate—urinary bladder cancer	0.000442	0.000599	CcSEcCtD
Gentamicin—Rash—Methotrexate—urinary bladder cancer	0.000439	0.000594	CcSEcCtD
Gentamicin—Dermatitis—Methotrexate—urinary bladder cancer	0.000438	0.000593	CcSEcCtD
Gentamicin—Headache—Methotrexate—urinary bladder cancer	0.000436	0.00059	CcSEcCtD
Gentamicin—LRP2—Metabolism—NQO1—urinary bladder cancer	0.000431	0.00669	CbGpPWpGaD
Gentamicin—Dizziness—Epirubicin—urinary bladder cancer	0.000431	0.000583	CcSEcCtD
Gentamicin—Pruritus—Doxorubicin—urinary bladder cancer	0.000426	0.000577	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—RBX1—urinary bladder cancer	0.000424	0.00658	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000418	0.00649	CbGpPWpGaD
Gentamicin—Vomiting—Epirubicin—urinary bladder cancer	0.000414	0.00056	CcSEcCtD
Gentamicin—Nausea—Methotrexate—urinary bladder cancer	0.000413	0.00056	CcSEcCtD
Gentamicin—Rash—Epirubicin—urinary bladder cancer	0.000411	0.000556	CcSEcCtD
Gentamicin—Dermatitis—Epirubicin—urinary bladder cancer	0.00041	0.000555	CcSEcCtD
Gentamicin—Headache—Epirubicin—urinary bladder cancer	0.000408	0.000552	CcSEcCtD
Gentamicin—Dizziness—Doxorubicin—urinary bladder cancer	0.000398	0.000539	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—TSC1—urinary bladder cancer	0.000398	0.00618	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000395	0.00614	CbGpPWpGaD
Gentamicin—LRP2—Disease—NCOR1—urinary bladder cancer	0.000394	0.00612	CbGpPWpGaD
Gentamicin—Nausea—Epirubicin—urinary bladder cancer	0.000387	0.000524	CcSEcCtD
Gentamicin—Vomiting—Doxorubicin—urinary bladder cancer	0.000383	0.000519	CcSEcCtD
Gentamicin—Rash—Doxorubicin—urinary bladder cancer	0.00038	0.000514	CcSEcCtD
Gentamicin—Dermatitis—Doxorubicin—urinary bladder cancer	0.00038	0.000514	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—JAG1—urinary bladder cancer	0.000379	0.00589	CbGpPWpGaD
Gentamicin—Headache—Doxorubicin—urinary bladder cancer	0.000377	0.000511	CcSEcCtD
Gentamicin—LRP2—Disease—ERCC2—urinary bladder cancer	0.000371	0.00576	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000365	0.00566	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GSTP1—urinary bladder cancer	0.000359	0.00558	CbGpPWpGaD
Gentamicin—Nausea—Doxorubicin—urinary bladder cancer	0.000358	0.000484	CcSEcCtD
Gentamicin—LRP2—Disease—MTHFR—urinary bladder cancer	0.000348	0.00541	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000348	0.0054	CbGpPWpGaD
Gentamicin—LRP2—Disease—TERT—urinary bladder cancer	0.000347	0.00539	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—TYMS—urinary bladder cancer	0.000334	0.00519	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GSTM1—urinary bladder cancer	0.00033	0.00513	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—NCOR1—urinary bladder cancer	0.00033	0.00513	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000322	0.00501	CbGpPWpGaD
Gentamicin—LRP2—Disease—FGFR3—urinary bladder cancer	0.000319	0.00495	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GPX1—urinary bladder cancer	0.000316	0.00491	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ERCC2—urinary bladder cancer	0.00031	0.00482	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—S100B—urinary bladder cancer	0.000307	0.00477	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—MTHFR—urinary bladder cancer	0.000292	0.00453	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NCOR1—urinary bladder cancer	0.000276	0.00429	CbGpPWpGaD
Gentamicin—LRP2—Disease—CREBBP—urinary bladder cancer	0.000271	0.00421	CbGpPWpGaD
Gentamicin—LRP2—Disease—RHOA—urinary bladder cancer	0.000246	0.00381	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TERT—urinary bladder cancer	0.000243	0.00378	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PPARG—urinary bladder cancer	0.000237	0.00367	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CREBBP—urinary bladder cancer	0.000227	0.00353	CbGpPWpGaD
Gentamicin—LRP2—Disease—ERBB2—urinary bladder cancer	0.000227	0.00353	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FGFR3—urinary bladder cancer	0.000223	0.00347	CbGpPWpGaD
Gentamicin—LRP2—Disease—PTGS2—urinary bladder cancer	0.000222	0.00345	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000218	0.00338	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ESR1—urinary bladder cancer	0.000217	0.00337	CbGpPWpGaD
Gentamicin—LRP2—Disease—CDKN1A—urinary bladder cancer	0.000194	0.00302	CbGpPWpGaD
Gentamicin—LRP2—Disease—PTEN—urinary bladder cancer	0.000194	0.00301	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CREBBP—urinary bladder cancer	0.00019	0.00295	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IGF1—urinary bladder cancer	0.000188	0.00291	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PTGS2—urinary bladder cancer	0.000186	0.00289	CbGpPWpGaD
Gentamicin—LRP2—Disease—EP300—urinary bladder cancer	0.000185	0.00287	CbGpPWpGaD
Gentamicin—LRP2—Disease—SRC—urinary bladder cancer	0.00018	0.00279	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—RHOA—urinary bladder cancer	0.000172	0.00267	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PTEN—urinary bladder cancer	0.000162	0.00252	CbGpPWpGaD
Gentamicin—LRP2—Disease—MYC—urinary bladder cancer	0.000161	0.0025	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ERBB2—urinary bladder cancer	0.000159	0.00247	CbGpPWpGaD
Gentamicin—LRP2—Disease—EGFR—urinary bladder cancer	0.000158	0.00245	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—EP300—urinary bladder cancer	0.000155	0.0024	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CXCL8—urinary bladder cancer	0.000151	0.00234	CbGpPWpGaD
Gentamicin—LRP2—Disease—KRAS—urinary bladder cancer	0.000149	0.00231	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL2—urinary bladder cancer	0.000144	0.00224	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CCND1—urinary bladder cancer	0.000141	0.00218	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MMP9—urinary bladder cancer	0.000137	0.00212	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CDKN1A—urinary bladder cancer	0.000136	0.00211	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PTEN—urinary bladder cancer	0.000136	0.00211	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EP300—urinary bladder cancer	0.000129	0.00201	CbGpPWpGaD
Gentamicin—LRP2—Disease—HRAS—urinary bladder cancer	0.000127	0.00196	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SRC—urinary bladder cancer	0.000126	0.00195	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MYC—urinary bladder cancer	0.000113	0.00175	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EGFR—urinary bladder cancer	0.00011	0.00171	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—KRAS—urinary bladder cancer	0.000104	0.00162	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000102	0.00158	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TP53—urinary bladder cancer	9.26e-05	0.00144	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HRAS—urinary bladder cancer	8.86e-05	0.00138	CbGpPWpGaD
